Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Heart Failure/drug therapy"" wg kryterium: Temat


Tytuł :
Empagliflozin in heart failure patients with reduced ejection fraction:a randomized clinical trial (Empire HF)
Autorzy :
Jensen, Jesper
Omar, Massar
Kistorp, Caroline
Poulsen, Mikael Kjær
Tuxen, Christian
Gustafsson, Ida
Køber, Lars
Gustafsson, Finn
Fosbøl, Emil
Bruun, Niels Eske
Videbæk, Lars
Frederiksen, Peter Hartmund
Møller, Jacob Eifer
Schou, Morten
Pokaż więcej
Temat :
Benzhydryl Compounds/adverse effects
Diabetes Mellitus, Type 2/complications
Double-Blind Method
Glucosides/adverse effects
Heart Failure/drug therapy
Humans
Natriuretic Peptide, Brain/blood
Peptide Fragments/blood
Quality of Life
Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
Stroke Volume/drug effects
Journal Article
Randomized Controlled Trial
Źródło :
Jensen, J, Omar, M, Kistorp, C, Poulsen, M K, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Fosbøl, E, Bruun, N E, Videbæk, L, Frederiksen, P H, Møller, J E & Schou, M 2019, ' Empagliflozin in heart failure patients with reduced ejection fraction : a randomized clinical trial (Empire HF) ', Trials, vol. 20, 374 . https://doi.org/10.1186/s13063-019-3474-5
Opis pliku :
application/pdf
Tytuł :
B-type natriuretic peptide-guided therapy for heart failure (HF):a systematic review and meta-analysis of individual participant data (IPD) and aggregate data
Autorzy :
Pufulete, Maria
Maishman, Rachel
Dabner, Lucy
Higgins, Julian P. T.
Rogers, Chris A.
Dayer, Mark
MacLeod, John
Purdy, Sarah
Hollingworth, William
Schou, Morten
Anguita-Sanchez, Manuel
Karlström, Patric
Shochat, Michael Kleiner
McDonagh, Theresa
Nightingale, Angus K.
Reeves, Barnaby C.
Pokaż więcej
Temat :
Natriuretic Peptide, Brain/blood
Bristol Heart Institute
Cause of Death
Research Support, Non-U.S. Gov't
Research
Heart Failure/drug therapy
IPD meta-analysis
Randomized Controlled Trials as Topic
Heart failure
B-type natriuretic peptide
Hospitalization
Meta-Analysis
Medicine
Systematic Review
Centre for Surgical Research
Mortality
Journal Article
Quality of Life
Humans
Źródło :
Pufulete, M, Maishman, R, Dabner, L, Higgins, J P T, Rogers, C A, Dayer, M, MacLeod, J, Purdy, S, Hollingworth, W, Schou, M, Anguita-Sanchez, M, Karlström, P, Shochat, M K, McDonagh, T, Nightingale, A K & Reeves, B C 2018, ' B-type natriuretic peptide-guided therapy for heart failure (HF) : a systematic review and meta-analysis of individual participant data (IPD) and aggregate data ', Systematic Reviews, vol. 7, 112 . https://doi.org/10.1186/s13643-018-0776-8
Pufulete, M, Maishman, R, Dabner, L, Higgins, J, Rogers, C, Dayer, M, Macleod, J, Purdy, S, Hollingworth, W, Schou, M, Anguita-Sanchez, M, Karlström, P, Kleiner Shochat, M, McDonagh, T, Nightingale, A & Reeves, B 2018, ' B-type natriuretic peptide-guided therapy for heart failure (HF) : a systematic review and meta-analysis of individual participant data (IPD) and aggregate data ', Systematic Reviews, vol. 7, 112 . https://doi.org/10.1186/s13643-018-0776-8
Systematic Reviews, Vol 7, Iss 1, Pp 1-21 (2018)
Opis pliku :
application/pdf
Tytuł :
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
Autorzy :
Jhund, Pardeep S.
McMurray, John J.V.
Mogensen, Ulrik M.
Gong, Jianjian
Shen, Li
Køber, Lars
Desai, Akshay S.
Lefkowitz, Martin P.
Packer, Milton
Rouleau, Jean L.
Solomon, Scott D.
Claggett, Brian L.
Swedberg, Karl
Zile, Michael R.
Mueller-Velten, Guenther
Pokaż więcej
Temat :
Focus on Prognostic Variables
Research Article
Angiotensin-Converting Enzyme Inhibitors/administration & dosage
Medical Therapy
Recurrent events
Research Support, Non-U.S. Gov't
Angiotensin Receptor Antagonists/administration & dosage
Heart Failure/drug therapy
Aminobutyrates/administration & dosage
Dose-Response Relationship, Drug
Stroke Volume/physiology
United States/epidemiology
Female
Heart failure
Survival Rate/trends
Hospitalization
Aged
Tetrazoles/administration & dosage
Middle Aged
Randomized Controlled Trial
Recurrence
Prospective Studies
Neprilysin inhibitor
Europe/epidemiology
Journal Article
Multicenter Study
Enalapril/administration & dosage
Humans
Male
Morbidity/trends
Źródło :
Mogensen, U M, Gong, J, Jhund, P S, Shen, L, Køber, L, Desai, A S, Lefkowitz, M P, Packer, M, Rouleau, J L, Solomon, S D, Claggett, B L, Swedberg, K, Zile, M R, Mueller-Velten, G & McMurray, J J V 2018, ' Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF) ', European Journal of Heart Failure, vol. 20, no. 4, pp. 760-768 . https://doi.org/10.1002/ejhf.1139
European Journal of Heart Failure
Opis pliku :
application/pdf
Tytuł :
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Autorzy :
Pölzl, Gerhard
Altenberger, Johann
Baholli, Loant
Beltrán, Paola
Borbély, Attila
Comin-Colet, Josep
Delgado, Juan F.
Fedele, Francesco
Fontana, Antonella
Fruhwald, Friedrich
Giamouzis, Gregory
Giannakoulas, George
Garcia-González, Martín J.
Gustafsson, Finn
Kaikkonen, Kari
Kivikko, Matti
Kubica, Jacek
von Lewinski, Dirk
Löfman, Ida
Malfatto, Gabriella
Manito, Nicolás
Martínez-Sellés, Martin
Masip, Josep
Merkely, Béla
Morandi, Fabrizio
Mølgaard, Henning
Oliva, Fabrizio
Pantev, Emil
Papp, Zoltán
Perna, Gian Piero
Pfister, Roman
Piazza, Vito
Bover, Ramón
Rangel-Sousa, Diego
Recio-Mayoral, Alejandro
Reinecke, Alexander
Rieth, Andreas
Sarapohja, Toni
Schmidt, Gunter
Seidel, Mirko
Störk, Stefan
Vrtovec, Bojan
Wikström, Gerhard
Yerly, Patrik
Pollesello, Piero
Pokaż więcej
Temat :
Elméleti orvostudományok
Clinical trial
Orvostudományok
Kardiologi
Administration, Oral
Cardiotonic Agents/administration & dosage
Clinical Trials as Topic/methods
Clinical Trials as Topic/standards
Consensus Development Conferences as Topic
Drug Administration Schedule
Europe/epidemiology
Evidence-Based Medicine/standards
Evidence-Based Medicine/trends
Heart Failure/diagnosis
Heart Failure/drug therapy
Heart Failure/epidemiology
Humans
Hydrazones/administration & dosage
Infusions, Intravenous
Pyridazines/administration & dosage
Rome/epidemiology
Advanced heart failure
Composite end-point
Intermittent
Levosimendan
Repetitive
VENTRICULAR FUNCTION
TRIAL
EUROPEAN-SOCIETY
OF-CARDIOLOGY
FOLLOW-UP
INFUSIONS
INTRAVENOUS LEVOSIMENDAN
Cardiac and Cardiovascular Systems
DOUBLE-BLIND
LONG-TERM
Źródło :
Poelzl, G, Altenberger, J, Baholli, L, Beltran, P, Borbely, A, Comin-Colet, J, Delgado, J F, Fedele, F, Fontana, A, Fruhwald, F, Giamouzis, G, Giannakoulas, G, Garcia-Gonzalez, M J, Gustafsson, F, Kaikkonen, K, Kivikko, M, Kubica, J, von Lewinski, D, Lofman, I, Malfatto, G, Manito, N, Martinez-Selles, M, Masip, J, Merkely, B, Morandi, F, Molgaard, H, Oliva, F, Pantev, E, Papp, Z, Perna, G P, Pfister, R, Piazza, V, Bover, R, Rangel-Sousa, D, Recio-Mayoral, A, Reinecke, A, Rieth, A, Sarapohja, T, Schmidt, G, Seidel, M, Stoerk, S, Vrtovec, B, Wikstroem, G, Yerly, P & Pollesello, P 2017, ' Repetitive use of levosimendan in advanced heart failure : need for stronger evidence in a field in dire need of a useful therapy ', International Journal of Cardiology, vol. 243, pp. 389-395 . https://doi.org/10.1016/j.ijcard.2017.05.081
International journal of cardiology, vol. 243, pp. 389-395
Opis pliku :
application/pdf
Tytuł :
β2-adrenergic receptor genotype influences the effect of nonselective vs. selective β-blockade on baroreflex function in chronic heart failure
Autorzy :
Truijen, Jasper
de Peuter, Olav R
Kim, Yu-Sok
van den Bogaard, Bas
Kok, Wouter E
Kamphuisen, Pieter W
van Lieshout, Johannes J
Pokaż więcej
Temat :
Baroreflex/drug effects
Receptors, Adrenergic, beta-2/physiology
Adrenergic beta-2 Receptor Antagonists/pharmacology
Chronic Disease
Heart Failure/drug therapy
Aged
Middle Aged
Female
Humans
Male
Genotype
Źródło :
International journal of cardiology, 153(2), 230 - 232. Elsevier Ireland Ltd
International Journal of Cardiology, 153(2), 230 - 2. Elsevier Ireland Ltd

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies